On October 26, 2023, the three-day CPHI Barcelona 2023 came to an end at the Fira de Barcelona in Barcelona, Spain. CPHI Barcelona 2023, the world’s largest trade fair for the pharmaceutical industry, gathers industry-leading biopharmaceutical companies, investors and collaborators from all over the world, and many collaborative activities are held during the event.

Laviana Pharma, as a technology-driven, innovative pharmaceutical contract development and manufacturing organization (CDMO), attended the event and demonstrated its latest results of innovation and R&D achieved with its global presence. Meanwhile, the executives of Laviana Pharma were invited to the sessions held on the event.

During the event, Laviana Pharma attracted the attention of many professional audience from all over the world by virtue of its strong technological strength and innovation ability, one-stop R&D and production capacity with high quality, standardization and great time advantage, and highly qualified professional team. The professional audience spoke highly of and showed strong interest in Laviana Pharma and sought for customized solutions, which further strengthened the cooperation with Laviana Pharma.

Laviana Pharma has been committed to providing global customers with high-quality and cost-effective one-stop CDMO services, especially in the field of small molecule APIs with many patented technologies and rich experience. After 20 years of technological innovation and industrialization application, Laviana Pharma has been recognized by global partners in the field of small molecule innovative drugs. Taking the opportunity of this event, Laviana Pharma hopes to further expand the European and other international markets, establish long-term strategic cooperative relationships with more partners, and become a flagship CDMO company.